E
Eva Harris
Researcher at University of California, Berkeley
Publications - 357
Citations - 26475
Eva Harris is an academic researcher from University of California, Berkeley. The author has contributed to research in topics: Dengue virus & Dengue fever. The author has an hindex of 84, co-authored 332 publications receiving 22718 citations.
Papers
More filters
Journal ArticleDOI
Dengue chat: A novel web and cellphone application promotes community-based mosquito vector control
Journal ArticleDOI
Virology under the Microscope—a Call for Rational Discourse
Felicia Goodrum,Anice C. Lowen,Seema S. Lakdawala,James C. Alwine,Arturo Casadevall,Michael J. Imperiale,Walter J. Atwood,Daphne C. Avgousti,Joel D. Baines,Bruce W. Banfield,Lawrence Banks,Sumita Bhaduri-McIntosh,Deepta Bhattacharya,Daniel Blanco-Melo,David Bloom,Adrianus C. M. Boon,Steeve Boulant,Curtis Brandt,Andrew J. Broadbent,C. Brooke,Craig Cameron,Samuel Campos,Patrizia Caposio,Gary Chan,Anna R. Cliffe,John M. Cioffi,Kathleen Collins,Blossom Damania,Michael Daugherty,Kari Debbink,James A. DeCaprio,Terence S. Dermody,Jimmy D. Dikeakos,Daniel DiMaio,Rhoel R. Dinglasan,W. Paul Duprex,Rebecca Ellis Dutch,Nels C. Elde,Michael Emerman,Lynn W. Enquist,Bentley A. Fane,Ana Fernandez-Sesma,Michelle L. Flenniken,Lori Frappier,Matthew B. Frieman,Klaus Frueh,Michaela U. Gack,Marta Maria Gaglia,Tom Gallagher,Denise A. Galloway,Adolfo García-Sastre,Adam P. Geballe,Britt A. Glaunsinger,Stephen P. Goff,Alexander L. Greninger,Meaghan H. Hancock,Eva Harris,Nicholas S. Heaton,Mark T. Heise,Ekaterina E. Heldwein,Brenda G. Hogue,Stacy M. Horner,Edward C. Hutchinson,Joseph M. Hyser,W Jackson,Robert F. Kalejta,Jeremy P. Kamil,Stephanie M. Karst,Frank Kirchhoff,David M. Knipe,Timothy F. Kowalik,Michael Lagunoff,Laimonis A. Laimins,Ryan A. Langlois,Adam S. Lauring,Benhur Lee,D. D. Leib,Shan Lu,Richard Longnecker,C Carolina López,Micah A. Luftig,Jennifer M. Lund,Balaji Manicassamy,Grant McFadden,Michael McIntosh,Andrew Mehle,W. Allen Miller,Ian Mohr,Cary A. Moody,Nathaniel J. Moorman,Anne Moscona,Bryan C. Mounce,Joshua Munger,Karl Münger,Eain Murphy,Mojgan H. Naghavi,Jay A. Nelson,Christopher J. Neufeldt,Janko Ž Nikolich,Christine M. O'Connor,Akira Ono,Walter A. Orenstein,David A. Ornelles,Jing Hsiung James Ou,J. Parker,Colin R. Parrish,Andrew Pekosz,Philip E. Pellett,Julie K. Pfeiffer,Richard K. Plemper,Stephen J. Polyak,John G. Purdy,Dohun Pyeon,Miguel E. Quiñones-Mateu,Rolf Renne,Charles M. Rice,John W. Schoggins,Richard J. Roller,Charles J. Russell,Rozanne M. Sandri-Goldin,Martin Sapp,Luis M. Schang,Scott Schmid,Stacey Schultz-Cherry,Bert L. Semler,Thomas Shenk,Guido Silvestri,Viviana Simon,Gregory M. Smith,Jonathan A. Smith,Katherine R Spindler,Megan L. Stanifer,Kanta Subbarao,Wesley I. Sundquist,Mehul S. Suthar,Troy C. Sutton,Andrew W. Tai,Vera L. Tarakanova,Benjamin R. tenOever,Scott A. Tibbetts,S. Mark Tompkins,Z. Toth,Koenraad Van Doorslaer,Marco Vignuzzi,Nicholas A. Wallace,Derek Walsh,Michael Seymour Weekes,J. Brice Weinberg,Matthew D. Weitzman,Sandra K. Weller,Sean P. J. Whelan,Elizabeth White,Bryan Williams,Christiane E. Wobus,Scott T. Wong,Andrew D. Yurochko +155 more
TL;DR: In this article , a broad group of working virologists seek to aid policy makers in navigating these controversial issues by offering their expertise, explaining the use of gain-of-function approaches in science, discuss the possible origins of SARS-CoV-2 and outline current regulatory structures that provide oversight for virological research in the United States.
Journal ArticleDOI
A step towards therapeutics for dengue
Scott B. Biering,Eva Harris +1 more
TL;DR: A compound called JNJ-A07 showed promising antiviral activity against dengue virus in mouse models of infection as mentioned in this paper, which is the most prevalent mosquito-borne viral disease in humans.
Journal ArticleDOI
Boosting can explain patterns of fluctuations of ratios of inapparent to symptomatic dengue virus infections.
Laura W. Alexander,Rotem Ben-Shachar,Leah C. Katzelnick,Guillermina Kuan,Angel Balmaseda,Eva Harris,Mike Boots +6 more
TL;DR: In this paper, the authors formulated mechanistic epidemiologic models to examine the effects of protecting homologous and heterologous boosting of the antibody response in preventing subsequent symptomatic DENV infection.
Journal ArticleDOI
Cost-effectiveness of community mobilization (Camino Verde) for dengue prevention in Nicaragua and Mexico: A cluster randomized controlled trial.
Cynthia A. Tschampl,Eduardo A. Undurraga,Robert J. Ledogar,Josefina Coloma,José Legorreta-Soberanis,Sergio Paredes-Solís,Jorge Arosteguí,Carlos Hernández-Alvarez,Eva Harris,Neil Andersson,Donald S. Shepard +10 more
TL;DR: Camino Verde, a community-based mobilization strategy to prevent and control dengue and other mosquito-borne diseases, was marginally cost-effective in Mexico and not cost- effective in Nicaragua, from a healthcare sector perspective.